We evaluated the feasibility, safety, and efficacy of the administration of 4 sequential doses (intravenously
administered on days 1, 4, 11, and 18) of cryopreserved bone marrow–…

This trial evaluated the feasibility and efficacy of the infusion of mesenchymal stem cells
expanded using human serum for the treatment of refractory acute or chronic graft-versus-host …

Background Recent findings suggest that a specific deletion of Dicer1 in mesenchymal stromal
cell-derived osteoprogenitors triggers several features of myelodysplastic syndrome in a …

Background Passive immunotherapy with convalescent plasma (CP) is a potential treatment
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …

The presence of cytogenetic aberrations on mesenchymal stem cells (MSC) from myelodysplastic
syndrome (MDS) patients is controversial. The aim of the study is to characterize bone …

Background Posterolateral spinal fusion with autologous bone graft is considered the “gold
standard” for lumbar degenerative disc disease (DDD) when surgical treatment is indicated. …

Since the beginning of the COVID-19 pandemic in December 2019, a relationship between
the ABO blood group type and the novel coronavirus SARS-CoV-2, the etiological agent of …

Background The standard practice in allogeneic stem cell transplant (allo SCT ) is to infuse
peripheral blood stem cells ( PBSC ) the same day or the day after collection once the patient …

Acute graft-versus-host disease (aGVHD) remains one of the most severe complications after
allogeneic transplantation; in particular, the presence of gut involvement has been related …

BACKGROUND: Posttransplant cytopenias are a severe complication after allogeneic stem
cell transplantation (allo‐SCT) and their origin is often multifactorial or unknown. They are …